From Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing:

Warren-Huff-Reata-CEO
Warren-Huff-Reata-CEO

Headshot of Reata Pharmaceuticals CEO Warren Huff, courtesy of the company